PARTICIPATE IN A TRIAL

The Clinical Trial Unit provides participants the opportunity to participate in clinical research within a supportive and safe environment. We are always looking for healthy volunteers and participants with health conditions to volunteer for a wide variety of trials. If you are interested in participating in our clinical trials please register your interest and you will be notified by email when a new trial becomes available for which you may be eligible. Alternatively please look through our list of current trials below and register for specific studies.

Register for trials

Current Trials

  

Cranberry in recurrent urinary tract infections

A randomised, double-blind, placebo controlled study to investigate the efficacy and safety of high strength cranberry in women with recurrent urinary tract infections (Cystitis).

Local contact 
Donna Reeves - Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone

(07) 5678 0350

Trial status

Active

Recruiting

Register

Find out more

  

Passive Immunisation against Hepatitis A

Validating the optimal dose of normal immunoglobulin for protection against Hepatitis A.

Local contact 
Dr Megan Young
Email
megan.young@griffith.edu.au
Telephone

(07) 5678 0624

Trial status

Active

Recruiting

Register

  

Malaria Vaccine Trial

This is a Phase 1b trial to examine the effectiveness of a novel malaria vaccine candidate..

Local contact 
Dr Danielle Stanisic
Email
glycomicstrials@griffith.edu.au
Telephone

(07) 5678 0286

Trial status

Active

Recruiting

Register

Chronic Fatigue Syndrome Trial

Integration of immunological, radiological and clinical investigations to discover the pathomechanism of CFS and accelerate the diagnosis and implementation of treatments for patients.

Local contact 
Tania Manning or Vivienne Hughes
Email
ncned@griffith.edu.au
Telephone
(07) 5678 9283
Trial status

Active

Recruiting

NCNED Trial

Completed Trials

 

Normal levels of a non-human sugar: N-glycolylneuraminic acid (NEU5Gc)

This study aims to investigate the levels of a potential cancer biomarker, the sugar Neu5Gc, in healthy, cancer-free men and women over the age of 18 before and after fasting.

Local contact

Dr Lucy Shewell
Email
Neu5Gclevels@griffith.edu.au
 

Anti-Ageing Trial

An open label study into the effects of a herbal medicine on cognitive function, quality of life and specific biomarkers associated with age-related decline in older adults.

Local contact 
Evelin Tiralongo - Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone

(07) 5678 0366

 
 

Probiotic and Shift work Study

Moderating the effect of sleep disruption/deprivation on gut health and the immune system with probiotics

Local contact 
Rebecca Ramsey
Email
probiotic-study@griffith.edu.au
 

Meningococcal Vaccine Trial

Immunogenicity, reactogenicity and safety of two formulations of Meningococcal ACWY conjugate vaccine in healthy adults 18 to 40 years of age.
Local contact 
Donna Reeves - Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone
(07) 5678 0350
 

Allergic Rhinitis Trial

Mapping allergic rhinitis networks: comparative analysis of the effects of a topical antihistamine, topical nasal steroid and a combined antihistamine and steroid on immune phenotype in allergic rhinitis.
Local contact
Dr Amanda Cox
Email
allergic.study@griffith.edu.au
Telephone

(07) 5678 0898

 

Ross River Virus Trial

A pilot study to investigate the effects of pentosan polysulfate sodium in Ross River virus induced arthralgia.
Local contact
Danielle O'Reilly - Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone

(07) 5552 7260

(07) 5678 0929

 

Diabetes Trial

Randomised, double-blind placebo controlled dose-ranging study of ZGN-1061 in overweight and obese subjects with Type 2 Diabetes Mellitus to evaluate glycemic control, safety and tolerability over 12 weeks.

Local contact 
Judy Coote - Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone
(07) 5678 0286
(07) 5678 0929
Trial status

Active

Not recruiting

 

Osteoarthritis Trial

A Phase 2b, randomised double-blind placebo controlled multi centre study to evaluate the effects of pentosan polysulfate sodium in treating subjects with osteoarthritis of the knee and subchondral bone marrow lesions.

Local contact
Danielle O'Reilly - Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone

(07) 5552 7260

(07) 5678 0929

 
  

Memory Recall Trial

BioNODS study: Exploring the biochemical relationship between nutrients, oxidative stress, dreams, short-term memory recall and the urine biomarker hydroxyhaemopyrrolin-2-one.

Local contact 
BioNODS research team
Email
bionods@griffith.edu.au
Telephone
(07) 5678 0362
 
 

Strep A Diagnostic Device Trial

A prospective multi-centre study of the performance of the Ellume-Lab Group A Strep Test versus culture for the rapid detection of Group A Streptococcus in participants with acute Pharyngitis.

Local contact
Danielle O'Reilly - Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone

(07) 5552 7260

(07) 5678 0929

 
 

Osteoarthritis Trial

A Phase 2A, Randomised, Double-Blind, Placebo-Controlled, Multiple Centre, Multiple-Dose Study to Assess the Efficacy and Safety of ZYN002 Administered as a Transdermal Gel to Patients with Knee Pain due to Osteoarthritis Synthetic Transdermal Cannabidiol for The Treatment of Knee Pain Due to Osteoarthritis

Local contact
Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone
(07) 5678 0929
 
 

Flu Diagnostic Device Trial

A prospective multi-centre study of the Ellume-Lab Flu A+B test and ITreat Flu A+B test performance versus viral culture and reverse transcriptase polymerase chain reaction.

Local contact
Danielle O'Reilly, Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone
(07) 5552 7260
(07) 5678 0929
 
 

Malaria Trial

A pilot study to examine the persistence and immunogenicity of Plasmodium falciparum 7G8 blood stag parasites following commencement of doxycycline chemoprophylaxis.

Local contact
Dr Danielle Stanisic
Email
glycomicstrials@griffith.edu.au
Telephone
(07) 5552 8051
 
 

Chronic Kidney Disease Trial

Dose finding study for Polysialylated Erytrhopoeitin (PSA-EPO) in Chronic Kidney disease (CKD) subjects.

Local contact
Clinical Trial Unit
Email
clinicaltrialunit@griffith.edu.au
Telephone
(07) 5678 0929
 
 

Malaria Trial

A pilot study in humans for purified Plasmodium Falciparum 7G8 parasites attenuated with Tafuramycin-A.

Local contact
Dr Danielle Stanisic
Email
glycomicstrials@griffith.edu.au
Telephone
(07) 5552 8051
 
 

Probiotics Trial

The effect of probiotics consumption on alcohol pharmacokinetics: A pilot study.

Local contact
Dr Chris Irwin
Email
c.irwin@griffith.edu.au
Telephone
(07) 5678 7344
 
 

Dementia Trial

Phase I/II placebo-controlled randomised clinical trial of Etanercept in Australian patients with progressive dementia.

Local contact
A/Prof. Steve Ralph
Email
alzheimers-trial@griffith.edu.au
 
 

Malaria Trial

A safety and tolerability study in humans for Plasmodium falciparum 7G8 blood stage parasites attenuated with different doses of Tafuramycin-A.

Local contact
Dr Danielle Stanisic
Email
glycomicstrials@griffith.edu.au
Telephone
(07) 5552 8051
 
 

Malaria Trial

Infectivity of the Plasmodium falciparum 7G8 malaria cell bank, MCB-004, in humans.

Local contact
Dr Danielle Stanisic
Email
glycomicstrials@griffith.edu.au
Telephone
(07) 5552 8051

For more information -

Refer to the publication

 

Elderberry Trial

Investigating the effectiveness of Elderberry capsules in the prevention of upper respiratory symptoms associated with long distance travel.

Local contact
A/Prof. Evelin Tiralongo
Email
e.tiralongo@griffith.edu.au
Telephone
(07) 5552 7098

For more information -

Refer to the publication

  

Further reading

If you are interested in finding out more about clinical trials in general you may also like to visit the following websites:

Contact us

Start your trial with us as a researcher or volunteer to be a part of our current trials.